Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis

[1]  Sandrine Perez,et al.  Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation , 2001, Oncogene.

[2]  T. Mizutani,et al.  Identification of SWI·SNF Complex Subunit BAF60a as a Determinant of the Transactivation Potential of Fos/Jun Dimers* , 2001, The Journal of Biological Chemistry.

[3]  J. L. Bos,et al.  Ras-Dependent Regulation of c-Jun Phosphorylation Is Mediated by the Ral Guanine Nucleotide Exchange Factor-Ral Pathway , 2000, Molecular and Cellular Biology.

[4]  D. Bar-Sagi,et al.  Ras and Rho GTPases A Family Reunion , 2000, Cell.

[5]  Sandrine Perez,et al.  Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors , 2000, Oncogene.

[6]  A. Balmain,et al.  High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model , 2000, Oncogene.

[7]  Tom Maniatis,et al.  Assembly of a Functional Beta Interferon Enhanceosome Is Dependent on ATF-2–c-jun Heterodimer Orientation , 2000, Molecular and Cellular Biology.

[8]  Tsonwin Hai,et al.  Transcriptional Autorepression of the Stress-inducible GeneATF3 * , 2000, The Journal of Biological Chemistry.

[9]  M. Malumbres,et al.  The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways , 2000, Oncogene.

[10]  E. Wagner,et al.  Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation , 2000, Oncogene.

[11]  Y. Nakatani,et al.  ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation , 2000, Nature.

[12]  P. Vogt,et al.  v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity , 2000, Molecular and Cellular Biology.

[13]  M. Castellazzi,et al.  Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo , 2000, Oncogene.

[14]  B. Ozanne,et al.  Krp1, a novel kelch related protein that is involved in pseudopod elongation in transformed cells , 2000, Oncogene.

[15]  J. Gutkind,et al.  Multiple Mitogen-Activated Protein Kinase Signaling Pathways Connect the Cot Oncoprotein to the c-junPromoter and to Cellular Transformation , 2000, Molecular and Cellular Biology.

[16]  E. Wagner,et al.  Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation , 2000, Nature Genetics.

[17]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[18]  R. Wisdom,et al.  AP-1: one switch for many signals. , 1999, Experimental cell research.

[19]  P. Vogt,et al.  Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Wasilenko,et al.  Enhanced cell motility and invasion of chicken embryo fibroblasts in response to JUN over‐expression , 1999, International journal of cancer.

[21]  Xing Shen,et al.  Smads bind directly to the Jun family of AP-1 transcription factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Verlaan,et al.  The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A , 1999, Oncogene.

[23]  R. Wolthuis,et al.  Ras caught in another affair: the exchange factors for Ral. , 1999, Current opinion in genetics & development.

[24]  S. Cook,et al.  The Repertoire of Fos and Jun Proteins Expressed during the G1 Phase of the Cell Cycle Is Determined by the Duration of Mitogen-Activated Protein Kinase Activation , 1999, Molecular and Cellular Biology.

[25]  M. Davis.  How Eden Lost Its Garden , 1999 .

[26]  Tsonwin Hai,et al.  ATF3 and stress responses. , 1999, Gene expression.

[27]  M. Hartl,et al.  Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation , 1998, Oncogene.

[28]  H. van Dam,et al.  Transcription Factor ATF2 Cooperates with v-Jun To Promote Growth Factor-Independent Proliferation In Vitro and Tumor Formation In Vivo , 1998, Molecular and Cellular Biology.

[29]  G. Viglietto,et al.  Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo , 1998, Oncogene.

[30]  G. Calothy,et al.  mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells , 1998, Oncogene.

[31]  P. Vogt,et al.  Glutaredoxin is a direct target of oncogenic jun , 1998, Oncogene.

[32]  P. Herrlich,et al.  Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. , 1998, Genes & development.

[33]  S. Harrison,et al.  Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA , 1998, Nature.

[34]  T. Maniatis,et al.  Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. , 1998, Molecular cell.

[35]  C. Der,et al.  Mas Oncogene Signaling and Transformation Require the Small GTP-Binding Protein Rac , 1998, Molecular and Cellular Biology.

[36]  N. Jones,et al.  p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. , 1998, Genes & development.

[37]  E. Wagner,et al.  Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis) , 1997, Oncogene.

[38]  J. D. Engel,et al.  The world according to Maf. , 1997, Nucleic acids research.

[39]  P. Vernier,et al.  The c-Jun-induced transformation process involves complex regulation of tenascin-C expression , 1997, Molecular and cellular biology.

[40]  H. Iba,et al.  Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1 , 1997, Oncogene.

[41]  Michael C. Ostrowski,et al.  Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1 , 1997, Molecular and cellular biology.

[42]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[43]  M. Yaniv,et al.  Transformation by ras modifies AP1 composition and activity , 1997, Oncogene.

[44]  B. Ozanne,et al.  AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44 , 1997, Molecular and cellular biology.

[45]  Dirk Bohmann,et al.  Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases , 1997, Science.

[46]  M. LaQuaglia,et al.  A cDNA encoding a putative 37 kDa leucine-rich repeat (LRR) protein, p37NB, isolated from S-type neuroblastoma cell has a differential tissue distribution. , 1996, Biochimica et biophysica acta.

[47]  T. Toda,et al.  A new group of conserved coactivators that increase the specificity of AP-1 transcription factors , 1996, Nature.

[48]  H. van Dam,et al.  The CR1 and CR3 domains of the adenovirus type 5 E1A proteins can independently mediate activation of ATF-2 , 1996, Journal of virology.

[49]  B. Spiegelman,et al.  Cellular transformation and malignancy induced by ras require c-jun , 1996, Molecular and cellular biology.

[50]  Y. Shi,et al.  Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300 , 1996, Molecular and cellular biology.

[51]  M. Castellazzi,et al.  Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization , 1996, Molecular and cellular biology.

[52]  A. Schulze,et al.  Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107 , 1996, Journal of virology.

[53]  X. Y. Li,et al.  Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. , 1996, Genes & development.

[54]  B. Chen,et al.  ATF3 Gene , 1996, The Journal of Biological Chemistry.

[55]  B. Spiegelman,et al.  c-fos is required for malignant progression of skin tumors , 1995, Cell.

[56]  M. Busslinger,et al.  Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron , 1995, Molecular and cellular biology.

[57]  H. van Dam,et al.  Modulation of AP‐1/ATF transcription factor activity by the adenovirus‐e1a oncogene products , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[58]  D. Bohmann,et al.  Intramolecular signal transduction in c‐Jun. , 1995, The EMBO journal.

[59]  I. Herr,et al.  ATF‐2 is preferentially activated by stress‐activated protein kinases to mediate c‐jun induction in response to genotoxic agents. , 1995, The EMBO journal.

[60]  J. N. Mark Glover,et al.  Crystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA , 1995, Nature.

[61]  P. Vernier,et al.  SPARC and thrombospondin genes are repressed by the c‐jun oncogene in rat embryo fibroblasts. , 1994, The EMBO journal.

[62]  H. Iba,et al.  Analysis of AP-1 function in cellular transformation pathways , 1994, Journal of virology.

[63]  N. Jones,et al.  Different binding specificities and transactivation of variant CRE's by CREB complexes. , 1994, Nucleic acids research.

[64]  W. Greene,et al.  Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.

[65]  T. Curran,et al.  The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun , 1993, Nature.

[66]  K. Kataoka,et al.  Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family , 1993, Journal of virology.

[67]  P. Herrlich,et al.  A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. , 1993, Cancer research.

[68]  P. Herrlich,et al.  Heterodimer formation of cJun and ATF‐2 is responsible for induction of c‐jun by the 243 amino acid adenovirus E1A protein. , 1993, The EMBO journal.

[69]  A. Baxevanis,et al.  Interactions of coiled coils in transcription factors: where is the specificity? , 1993, Current opinion in genetics & development.

[70]  M. Hadman,et al.  Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[71]  K. Struhl,et al.  Yeast GCN4 as a probe for oncogenesis by AP-1 transcription factors: transcriptional activation through AP-1 sites is not sufficient for cellular transformation. , 1992, Genes & development.

[72]  P. Herrlich,et al.  ULTRAVIOLET‐RADIATION INDUCED c‐jun GENE TRANSCRIPTION: TWO AP‐1 LIKE BINDING SITES MEDIATE THE RESPONSE , 1992, Photochemistry and photobiology.

[73]  P. S. Kim,et al.  Mechanism of specificity in the Fos-Jun oncoprotein heterodimer , 1992, Cell.

[74]  P. Vogt,et al.  Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[75]  M. Karin,et al.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 , 1991, Nature.

[76]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[77]  M. Yaniv,et al.  Overexpression of c-jun, junB, or junD affects cell growth differently. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[78]  B. Wasylyk,et al.  Transformation suppressor activity of a Jun transcription factor lacking its activation domain , 1991, Nature.

[79]  M. Karin,et al.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain , 1991, Nature.

[80]  J. Hsu,et al.  Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Tsonwin Hai,et al.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[82]  R. Müller,et al.  Non-leucine residues in the leucine repeats of Fos and Jun contribute to the stability and determine the specificity of dimerization. , 1991, Nucleic acids research.

[83]  C. Chang,et al.  Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. , 1990, Genes & development.

[84]  W. DeGrado,et al.  Design of DNA-binding peptides based on the leucine zipper motif. , 1990, Science.

[85]  P. S. Kim,et al.  Sequence-specific DNA binding by a short peptide dimer. , 1990, Science.

[86]  Michael R. Green,et al.  A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein , 1990, Cell.

[87]  H. Iba,et al.  Isolation and characterization of fra-2, an additional member of the fos gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. Visvader,et al.  Trans-dominant negative mutants of Fos and Jun. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[89]  I. Verma,et al.  mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element , 1990, Molecular and cellular biology.

[90]  Tsonwin Hai,et al.  Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. , 1989, Genes & development.

[91]  M. Karin,et al.  Different requirements for formation of Jun: Jun and Jun: Fos complexes. , 1989, Genes & development.

[92]  K. Kataoka,et al.  v-maf, a viral oncogene that encodes a "leucine zipper" motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[93]  A. Schönthal,et al.  Autoregulation of fos: the dyad symmetry element as the major target of repression. , 1989, The EMBO journal.

[94]  Peter Angel,et al.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 , 1988, Cell.

[95]  T. Hunter,et al.  The c-fos protein interacts with c-Jun AP-1 to stimulate transcription of AP-1 responsive genes , 1988, Cell.

[96]  I. Verma,et al.  Transcriptional autoregulation of the proto-oncogene fos , 1988, Nature.

[97]  P. Vogt,et al.  Avian sarcoma virus 17 carries the jun oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[98]  R. Jove,et al.  Cell transformation by the viral src oncogene. , 1987, Annual review of cell biology.